Document Detail


Neuroleptic malignant syndrome and catatonia. A report of three cases.
MedLine Citation:
PMID:  7913834     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a series of 1007 consecutively admitted patients, 3 cases of neuroleptic malignant syndrome (NMS) were identified (0.3%). All three patients were affected by mood disorders with congruent psychotic features, had shown catatonia just before the onset of NMS, and had been treated with low neuroleptic doses. All of them presented low serum iron levels. The relationship between NMS and catatonia and possible therapeutic decisions are discussed.
Authors:
M Raja; M C Altavista; S Cavallari; L Lubich
Related Documents :
18986394 - Quick resolution of takotsubo cardiomyopathy: a brief review.
24248814 - Hibernomas: a single-institution experience and review of literature.
12498614 - Syngnathia and van der woude syndrome: a case report and literature review.
9208244 - The marshall-smith syndrome: a review of the laryngeal complications.
22784524 - Unilateral keratoderma in a mother and her son.
9617514 - Alprazolam withdrawal delirium: a case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  European archives of psychiatry and clinical neuroscience     Volume:  243     ISSN:  0940-1334     ISO Abbreviation:  Eur Arch Psychiatry Clin Neurosci     Publication Date:  1994  
Date Detail:
Created Date:  1994-08-31     Completed Date:  1994-08-31     Revised Date:  2009-05-11    
Medline Journal Info:
Nlm Unique ID:  9103030     Medline TA:  Eur Arch Psychiatry Clin Neurosci     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  299-303     Citation Subset:  IM    
Affiliation:
Ospedale Santo Spirito, Dipartimento di salute mentale USL RM11, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / administration & dosage,  adverse effects*
Bipolar Disorder / drug therapy*,  psychology
Catatonia / chemically induced*,  diagnosis,  therapy
Depressive Disorder / drug therapy*,  psychology
Dibenzothiazepines / administration & dosage,  adverse effects
Dose-Response Relationship, Drug
Drug Therapy, Combination
Fatal Outcome
Female
Haloperidol / administration & dosage,  adverse effects
Humans
Infusions, Intravenous
Male
Middle Aged
Neuroleptic Malignant Syndrome / diagnosis*,  therapy
Neurologic Examination / drug effects
Psychotic Disorders / drug therapy*,  psychology
Retrospective Studies
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Dibenzothiazepines; 52-86-8/Haloperidol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Limited proteolysis study of structure-function relationships in Sh I, a polypeptide neurotoxin from...
Next Document:  Aspects of histocompatibility and regeneration in the solitary reef coral Fungia scutaria.